PIK3CA and lymphatic malformation: T2-weighted magnetic resonance imaging (MRI) has proven to be the primary method to quantify lymphatic malformation volume in patients and was used to exhibit the efficacy of alpelisib in the Pik3ca mouse lymphatic malformation model prior injection into humans, serving as a critical translational tool to be used for target validation (102).